SCHEMBL6137680

SCHEMBL6137680

CC(C)(C)OC(=O)N(CCCc1ccc2c(c1)N=C(N)C1(F)CCCC21)Cc1cccc(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 10/20 0.61
NOS1 P29475 10/20 0.61
NOS2 P35228 10/20 0.61
HTR4 Q13639 4/20 0.34
CPB2 Q96IY4 1/20 0.33
GHSR Q92847 3/20 0.32
GRM2 Q14416 1/20 0.32
GRM3 Q14832 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137765 0.84 NOS3 (0.40) NOS3NOS1NOS2HTR4CPB2
SCHEMBL7175631 0.83 NOS3 (0.40) NOS3NOS1NOS2HTR4CPB2
SCHEMBL6069204 0.78 NOS3 (0.56) NOS3NOS1NOS2GHSRGRM2
SCHEMBL6139875 0.76 NOS3 (1.00) NOS3NOS1NOS2
SCHEMBL6069478 0.74 NOS3 (0.59) NOS3NOS1NOS2GHSR
SCHEMBL6069538 0.71 NOS3 (0.57) NOS3NOS1NOS2GHSR
SCHEMBL16468452 0.70 AOC3 (0.44) GRM2GRM3
SCHEMBL7704970 0.70 NOS3 (0.34) NOS3NOS1NOS2GHSRHTR2A
SCHEMBL2262829 0.69 RIPK1 (0.47)
SCHEMBL18994886 0.69 HDAC1 (0.41) HTR4GRM2GRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed